Use of progesterone as a preventive medicine and nifedipine as a treatment of preterm labor

被引:0
作者
Kim, Yun-Sook [1 ]
机构
[1] Soonchunhyang Univ, Cheonan Hosp, Dept Obstet & Gynecol, Cheonan, South Korea
来源
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | 2018年 / 61卷 / 03期
关键词
Obstetric labor; premature; Progesterone; Nifedipine; Prevention & control;
D O I
10.5124/jkma.2018.61.3.214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Preterm birth is a major cause of neonatal morbidity and mortality, and occurs in 5% to 15% of all pregnancies. Therefore, its prevention is a major opportunity to reduce medical costs and to promote public health in all countries. Preterm birth is a broad great obstetric syndrome that arises from a wide variety of causes. Although many therapeutic agents are used for premature labor, most of them have serious maternal side effects, and they are ineffective in cases when labor has already begun. Therefore, the authors would like to introduce progesterone, as a treatment to prevent preterm labor. We also investigated whether nifedipine, which is used to treat preterm labor, could prevent preterm labor. We are eager to find more effective and easier-to-use drugs to prevent preterm labor in the future.
引用
收藏
页码:214 / 218
页数:5
相关论文
共 30 条
  • [1] Abate A., 1997, Clinical and Experimental Obstetrics and Gynecology, V24, P190
  • [2] Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate
    Bailit, Jennifer L.
    Votruba, Mark E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (03) : 219 - 220
  • [3] BENEDETTI TJ, 1983, AM J OBSTET GYNECOL, V145, P1
  • [4] Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial
    Borna, Sedigheh
    Sahabi, Noshin
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2008, 48 (01) : 58 - 63
  • [5] Maintenance oral nifedipine for preterm labor: A randomized clinical trial
    Carr, DB
    Clark, AL
    Kernek, K
    Spinnato, JA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (04) : 822 - 827
  • [6] Progesterone for the prevention of preterm birth - A systematic review
    Dodd, Jodie M.
    Flenady, Vicki J.
    Cincotta, Robert
    Crowther, Caroline A.
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 112 (01) : 127 - 134
  • [7] Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise
    Elovitz, M
    Wang, Z
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (03) : 693 - 701
  • [8] Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?
    Elovitz, MA
    Mrinalini, C
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (03) : 1149 - 1155
  • [9] The use of progestational agents for preterm birth: Lessons from a mouse model
    Elovitz, Michal A.
    Mrinalini, Conjeevaram
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (04) : 1004 - 1010
  • [10] NIFEDIPINE PHARMACOKINETICS DURING PRETERM LABOR TOCOLYSIS
    FERGUSON, JE
    SCHUTZ, T
    PERSHE, R
    STEVENSON, DK
    BLASCHKE, T
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) : 1485 - 1490